secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dare Bioscience, Inc. (DARE)
CIK:        0001401914
Form:       8-K
Filed at:   2026-01-29T23:59:59+00:00
Accession:  0001493152-26-004245
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 3.02, 8.01, 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Daré Bioscience closes initial tranche of Reg A offering at $5/unit; issues 5,090 units
--------------------------------------------------------------------------------

- Initial closing on Jan 27, 2026: issued 5,090 Units (each 1 share Series A Preferred + 2 warrants) for $25,450 gross proceeds.
- Series A Preferred convertible at $2.50/share, no dividends, liquidation preference $5/share, senior to common stock.
- Investor warrants exercisable at $4.00/share for 36 months; Agent warrants at $6.25/unit, subject to 180-day lock-up.
- Company can call preferred after 3 years at lesser of stated value + 8% annual or 200% of stated value.
- Forced conversion triggers: change of control, stock price ≥$4.50 for 10 of 30 days, or firm IPO ≥$15M at ≥$4.50.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401914/000149315226004245/0001493152-26-004245-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401914/000149315226004245/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-004245

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer